Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
Status:
RECRUITING
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This phase IV trial compares patient satisfaction with telehealth versus in-person neuro-oncology assessments among glioma patients receiving oral chemotherapy. Gliomas are the most common primary central nervous system cancer and are associated with a high symptom burden, such as drowsiness, fatigue, memory difficulty, and difficulty communicating. Care at a high volume center is associated with an overall survival benefit, however, many patients may have physical or financial difficulties preventing access to these centers. Telehealth visits use computers, cameras, videoconferencing, the internet, satellite, and wireless communications to deliver healthcare, while in-person visits require the interaction to take place in the physical presence of someone else. Telehealth neuro-oncology assessments may be preferable compared to in-person assessments in glioma patients receiving oral chemotherapy.
Phase:
PHASE4
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Observational Studies as Topic Outcome Assessment, Health Care Restraint, Physical Temozolomide